Hovione India

Office

Deliver Global Solutions with Local Execution.

Recognizing the importance of Indian Pharma market and its growing global presence including US, Hovione has decided to open office in India in 2011 and established fully functional office in Mumbai in April 2013.

 

This was a significant initiative in line with Company’s commitment to serve Pharmaceutical Customers well by understanding their needs and provide them proficient support to bring new and off-patent drugs to market. Today, Hovione India office is networking with several leading pharma companies and supporting their generic drug development projects for India, US and other regulated markets. 

 

Goal of Hovione India

  • Deliver Global Solutions with Local Execution
  • Facilitate smooth interaction between Hovione and Pharmaceutical Companies
  • Focused attention to support new projects and product development
  • Strengthen relationship with Indian Pharmaceutical Companies

Hovione's APIs offer impeccable chemical purity and unique product performance.

You might be interested in:

Minocycline

 

Minocycline Hydrochloride

Minocycline base

Doxycycline

 

Doxycycline monohydrate

Doxycycline hyclate

Ivermectin

Ivermectin

 

Download our Integrated Product List

 

 

Knowledge Center

ARTICLE

Gaining Experience in Continuous Manufacturing

Experts at Hovione describe progress being made in understanding how to optimize continuous processes for oral solid-dosage drug products.
Source: PharmTech

ARTICLE

A multicentre, randomized, double‐masked, parallel group, vehicle‐controlled phase IIb study

to evaluate the safety and efficacy of 1% and 3% topical minocycline gel in patients with papulopustular rosacea
Source: British Journal of Dermatology

POSTER

Improving Efficiency of Taste Making through Spray Congealing

Source: AAPS

 

 

For inquiries about Hovione India, kindly fill the form below.

News

Lisbon, Portugal – Hovione, the specialist integrated pharma CDMO and leader in spray drying and particle engineering, today announced its commitment to setting Science-Based Targets (SBTs) in line with the Paris Agreement. This ambitious step underscores the company’s dedication to addressing climate change and driving sustainability across its operations. By committing to SBTs, Hovione joins a growing number of businesses taking concrete actions to reduce greenhouse gas emissions. This initiative aligns with the company’s broader sustainability strategy and reinforces its commitment to scientific excellence. “At Hovione, we believe in science and in best practices. And this clearly applies to our sustainability agenda.”, said Jean-Luc Herbeaux, CEO of Hovione. We made the decision to drive our GHG emissions down using a science-based target setting process, which will help us drive sustainability across our operations by laying out a clearly defined path to reduce emissions in line with the Paris Agreement goals. We believe that by setting ambitious targets and implementing concrete actions, we can make a positive impact on the planet while driving innovation and growth.” Hovione will work closely with the Science Based Targets initiative (SBTi) to develop and validate its emission reduction targets. The company will provide regular updates on its progress towards achieving these goals. As part of its commitment to sustainability and transparency to stakeholders, the company will enhance its Ecovadis rating. Ecovadis, a leading sustainability assessment platform in the pharmaceutical industry, provides a comprehensive evaluation of a company’s environmental, social, and ethical performance, well aligned with Hovione’s sustainability ambitions.  Hovione remains dedicated to operating responsibly and contributing positively to society and the environment. The company will continue to implement sustainable practices across its operations and innovate to further improve its sustainability rating.   Learn more about Science Based-Targets  

News

Hovione Commits to Science-Based Targets for Greenhouse Gas (GHG) Emissions

Sep 09, 2024
Office
Address

Hovione Holding Limited
C/o WeWork, 2nd floor,
Oberoi Commerz - II,  1,
Off Western Express Highway,
Oberoi Garden City, Goregaon East, Mumbai, Maharashtra 400063
India
Tel.: +919 004 261 523

FDA logo | Hovione
infarmed logo | Hovione
Hovione MACAU - ISO14001 and ISO45001
HKQAA Certified Company | Hovione

Other Locations

Hovione Hong Kong

Office
Address

Hovione Holding Asia Limited
Aubin House, 11th Floor
171-172 Gloucester Road
Wanchai
Hong Kong SAR
Tel.: +852 2891 1836
Fax: +852 2891 0943 

Hovione Beijing

Office
Address

Hovione (Shanghai) Pharma Technology Limited Beijing Branch
Room 1003-1, 10/F, Sanyuan NEO Xinjing Building, Building 18, No. 5 Shuguang Xili, Chaoyang District, Beijing, China
Tel.: +86-18500027185
Tel.: +86-19931153253 

contact@hovione.com